Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
44.22
+0.75 (1.73%)
Dec 20, 2024, 4:00 PM EST - Market closed
Ultragenyx Pharmaceutical Analyst Ratings
Total Analysts
14
Consensus Rating
Strong Buy
Price Target
$88.43
Upside
+99.98%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $75 → $88 | Buy | Maintains | $75 → $88 | +99.00% | Dec 20, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $105 → $102 | Buy | Maintains | $105 → $102 | +130.66% | Nov 21, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $121 | Strong Buy | Maintains | $121 | +173.63% | Nov 12, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $109 → $121 | Strong Buy | Maintains | $109 → $121 | +173.63% | Nov 6, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $77 | Buy | Reiterates | $77 | +74.13% | Nov 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $116 | Buy | Reiterates | $116 | +162.32% | Nov 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $82 → $95 | Strong Buy | Maintains | $82 → $95 | +114.83% | Nov 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $116 | Buy | Reiterates | $116 | +162.32% | Oct 22, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $61 → $73 | Strong Buy | Maintains | $61 → $73 | +65.08% | Oct 21, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $116 | Buy | Reiterates | $116 | +162.32% | Oct 1, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $77 | Buy | Reiterates | $77 | +74.13% | Sep 26, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $116 | Buy | Reiterates | $116 | +162.32% | Sep 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $116 | Buy | Reiterates | $116 | +162.32% | Sep 16, 2024 |
| Barclays | Barclays | Buy Maintains $83 → $81 | Buy | Maintains | $83 → $81 | +83.18% | Aug 5, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $72 → $75 | Buy | Maintains | $72 → $75 | +69.61% | Aug 2, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $67 → $76 | Strong Buy | Maintains | $67 → $76 | +71.87% | Aug 2, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.